Rezolute Inc Ordinary Shares RZLT 深 滬
等待開盤 12-18 09:30:00 美东时间
2.01
-0.010
-0.50%
華盛通- 最 高2.25
- 今 開2.05
- 成交量 1593.73万股
- 最 低 1.84
- 昨 收 2.02
- 總市值 1.75亿
- 52周最高 11.4565
- 市盈率 靜 --
- 換手率 0.02%
- 52周最低 1.07
- 委 比 -36.44%
- 總股本 8699.60万
- 歷史最高 21.11
- 量 比 0.39
- 振 幅 20.30%
- 歷史最低 0.72
- 每 手 1
- 風險率 2.34%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股牛股 | B Riley金融大涨超53%，补交逾期第二季度报告，该季度实现扭亏为盈；Rezolve涨28%
B Riley金融大涨超53%，补交逾期第二季度报告，该季度实现扭亏为盈；Rezolve涨28%，预计年度经常性收入突破2亿美元，大幅超越此前目标>>
12-17 18:50
美股大行评级 | 博通、Lululemon获10逾家大行上调目标价；好市多、RH遭大行下调目标价
今日重点评级关注：杰富瑞：维持ImmunityBio Inc Ordinary Shares"买入"评级，目标价从8美元升至9美元；B. Riley证券：维持WAVE Life Sciences"买入"评级，目标价从19美元升至37美元
12-15 15:30
Why Is XOMA Royalty Stock Sinking Thursday?
XOMA stock plunged after its partner Rezolute Inc. reported disappointing trial results for their product Ersodetug.
12-12 02:09
Rezolute shares are trading lower after the company said its Phase 3 sunRIZE study of Ersodetug in congenital hyperinsulinism did not meet the primary or key secondary endpoint.
Rezolute shares are trading lower after the company said its Phase 3 sunRIZE st...
12-11 20:46
Rezolute Files For Mixed Shelf Offering, Size Not Disclosed
Debt SecuritiesCommon StockPreferred StockWarrantsSubscription RightsPurchase ContractsDepositary SharesUnitsWe, or, under certain circumstances, one or more selling securityholders to be identified in the future, may
12-06 06:33
美股大行评级 | 最高352美元！14家机构连夜上调英伟达目标价；劳氏、塔吉特、Wix.com等遭多家机构下调目标价
今日重点评级关注：Ascendiant Capital：维持Aclarion"买入"评级，目标价从22美元升至23美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从24美元升至26美元
11-21 15:50
BTIG Reiterates Buy on Rezolute, Maintains $17 Price Target
BTIG analyst Julian Harrison reiterates Rezolute (NASDAQ:RZLT) with a Buy and maintains $17 price target.
11-20 21:02
Rezolute Q1 EPS $(0.18) Beats $(0.26) Estimate
Rezolute (NASDAQ:RZLT) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.26) by 31.3 percent. This is a 18.18 percent increase over losses of $(0.22) per share from the same
11-07 06:11
美股大行评级 | 275美元！美银证券上调英伟达目标价；花旗上调思佳讯评级至"中性"，目标价从66美元升至91美元
今日重点评级关注：HC Wainwright & Co.：维持Unicycive Therapeutics"买入"评级，目标价从9美元升至22美元；花旗：维持Arcus Biosciences"买入"评级，目标价从54美元升至56美元
10-30 14:22
Citizens Maintains Market Outperform on Rezolute, Raises Price Target to $17
Citizens analyst Jason N. Butler maintains Rezolute (NASDAQ:RZLT) with a Market Outperform and raises the price target from $9 to $17.
10-30 00:02
